HSAN-2A

WNK1 | 2008

What Is HSAN-2A?

HSAN-2A is a type of CMT caused by autosomal recessive mutations in the WNK1 gene. This gene provides instructions for making a protein kinase that helps regulate ion balance and signaling in the sensory nervous system. Mutations in the WNK1 gene disrupt this function, leading to impaired nerve signal transmission.

HSAN-2A is autosomal recessive, meaning that both copies of the gene must have a mutation to cause this subtype.

Clinical Features

The age of symptom onset in HSAN-2A is variable, ranging from childhood to adulthood. The disease involves loss of sensation that begins in the hands and feet (glove-and-stocking distribution) and progresses over time towards the center of the body. Nerve conduction studies usually show somewhat slowed conduction velocities and reduced amplitudes, consistent with an axonal form of CMT.

HSAN-2A symptoms may include:

  • Progressive loss of sensation in the feet and hands
  • Loss of pain and temperature sensation
  • Reduced or absent reflexes
  • Foot deformities, including high arches, and hammertoes (clawed toes)
  • Distal weakness that develops as the disease progresses
  • Foot drop
  • Additional symptoms not listed here

Disease Course

HSAN-2A shows wide variability in severity and progression. Some individuals are mildly affected, while others develop a more severe disease. Disease progression is generally slow, and life expectancy is not reduced.

Clinical Basics

Subtype
HSAN-2A

Classification
HSAN

Neuropathy Type
Axonal

Inheritance Pattern
autosomal recessive

Genetic Context

HGNC-Approved Gene Symbol
WNK1

Gene Full Name
WNK lysine deficient protein kinase 1

Chromosome
12p13.33

Zygosity of Responsible Variant
Homozygous

Variant Mechanism

Loss of Function (LoF)

Details

Mechanistic basis:
Complete loss

Confidence:
High

Prediction:
The literature predicts a biallelic loss-of-function mechanism for HSAN-2A: recessive truncating variants cluster in HSN2, the nervous-system-specific exon of WNK1, and remove the neuronal isoform while leaving the ubiquitously expressed kinase intact. Both copies of that isoform must be lost before disease appears. Restored wild-type is predicted to rescue. Separate WNK1 alleles that raise kinase signaling cause pseudohypoaldosteronism type II, a hypertension disorder, so the two directions of effect at this locus give unrelated diseases.

Rationale:
Because the truncations fall in an exon used only by the neuronal transcript, the deficit is confined to the WNK1/HSN2 isoform, which explains why single-allele carriers are unaffected and why the kinase's renal functions are spared. Gain-of-function WNK1 alleles at the same locus drive hypertension instead, making direction of effect rather than the gene the determinant of phenotype.

ClinVar Pathogenic Variants

View WNK1 ClinVar Variants

HSAN-2A OMIM Entry

HSAN-2A OMIM

WNK1 OMIM Entry

WNK1 OMIM

More Info

HSAN-2A Research Opportunity

CMT Natural History Study

Original Discovery Publication

Publication Title

Mutations in the Nervous System–Specific HSN2 Exon of WNK1 Cause Hereditary Sensory Neuropathy Type II

Authors

Shekarabi, M., Girard, N., Rivière, J. B., Dion, P., Houle, M., Toulouse, A., Lafrenière, R. G., Vercauteren, F., Hince, P., Laganiere, J., Rochefort, D., Faivre, L., Samuels, M., & Rouleau, G. A.

Publication Date
June 2, 2008

Updated: July 18, 2026 | By: K. Raymond

The Dorsal Root

More From The Dorsal Root


A Name That Does Too Much Work

Jean-Martin Charcot's name appears throughout medicine, but nowhere does it create more confusion than in the foot. Learn why the CMT foot and Charcot neuroarthropathy, also known as Charcot foot, share a name yet differ in how they develop, appear, and are managed.


When Medicine Lost Its Compass

Evidence failed not because it was wrong, but because it was weaponized. I lived the downstream effects of that failure for more than a decade. This is what happens when medicine forgets that data always ends in a human being.


Error 404: Gene Not Found

CMT genetic testing often fails to identify the cause of the disease, even when comprehensive panels are used. Here, we discuss why this happens, what genetic tests can and cannot do, and why a negative result still matters.